相关实验视频
Updated: Jan 16, 2026
07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
9.3K
营养状况不是儿童队列中过敏症严重程度的预测因素:回顾性分析
Izabela Kucharek1, Krzysztof Przystał-Dyszyński1, Aleksandra Godyńska1
1Clinical Department of Pediatrics and Allergology, National Medical Institute of the Ministry of the Interior and Administration, 02-507 Warsaw, Poland.
Nutrients
|September 27, 2025
概括
儿童肥胖并不能预测儿童过敏反应的严重程度. 这项研究发现,身体质量指数 (BMI) 与住院青少年的严重过敏反应之间没有联系,与成人不同.
科学领域:
- 儿科过敏和免疫学
- 营养科学 营养科学
- 公共卫生 公共卫生
背景情况:
- 儿童肥胖是一种促炎症状态,与喘等过敏性疾病的恶化结果有关.
- 在成年人中,肥胖是严重过敏反应的危险因素,但这种关联在儿童中不清楚.
研究的目的:
- 研究身体质量指数 (BMI) 与住院儿童过敏反应的严重程度和表现之间的关系.
- 为了确定营养状况是否影响儿科患者的过敏反应结果.
主要方法:
- 对199名患有过敏反应的住院儿童 (0-18岁) 的回顾性分析.
- 使用身体质量指数 (BMI) 分类营养状况:体重不足,正常体重,超重和肥胖.
- 使用世界过敏组织 (WAO) 的分级和对BMI组的临床表现的分析来评估过敏症的严重程度.
主要成果:
- 在BMI类别和过敏反应严重程度之间没有发现统计学意义上的关联 (p = 0.861).
- 在所有BMI组中,严重的过敏反应 (WAO 4-5级) 是不常见的.
- 调整后的回归分析表明,BMI不是对儿童过敏反应严重程度或器官系统参与的独立预测指标.
结论:
- 按BMI测量的营养状况不能预测这个儿科队列中过敏反应的严重程度或呈现.
- 肥胖作为严重过敏反应的危险因素的作用可能取决于年龄,在儿童和成人之间有所不同.
- 研究结果表明,当将成人过敏反应数据推断到儿科患者群体时,需要谨慎.
相关概念视频
02:06Allergic Reactions
32.0K
Overview
32.0K
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
246
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
246
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
254
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
254
01:27Allergic Drug Reactions
1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
193
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
193
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
212
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212